image
image
user-login
Patent search/

HETEROCYCLIC INHIBITORS OF EGFR AND/OR HER2, FOR USE IN THE TREATMENT OF CANCER

Patent Search in India

  • tick

    Extensive patent search conducted by a registered patent agent

  • tick

    Patent search done by experts in under 48hrs

₹999

₹399

Talk to expert

HETEROCYCLIC INHIBITORS OF EGFR AND/OR HER2, FOR USE IN THE TREATMENT OF CANCER

PCT NATIONAL PHASE APPLICATION

Published

date

Filed on 8 May 2023

Patent Information

Application ID202317032404
Date of Application08/05/2023

Documents

NameDate
202317032404-FORM 3 [03-11-2023(online)].pdf03/11/2023
202317032404-FORM-26 [08-08-2023(online)].pdf08/08/2023
202317032404.pdf13/05/2023
202317032404-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [08-05-2023(online)].pdf08/05/2023
202317032404-COMPLETE SPECIFICATION [08-05-2023(online)].pdf08/05/2023
202317032404-DECLARATION OF INVENTORSHIP (FORM 5) [08-05-2023(online)].pdf08/05/2023
202317032404-FORM 1 [08-05-2023(online)].pdf08/05/2023
202317032404-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [08-05-2023(online)].pdf08/05/2023
202317032404-PRIORITY DOCUMENTS [08-05-2023(online)].pdf08/05/2023
202317032404-PROOF OF RIGHT [08-05-2023(online)].pdf08/05/2023
202317032404-Sequence Listing in PDF [08-05-2023(online)].pdf08/05/2023
202317032404-Sequence Listing in txt [08-05-2023(online)].txt08/05/2023
earn

Refer a friend